| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0469-0625-99 | 0469-0625 | HUMAN PRESCRIPTION DRUG | Xtandi | enzalutamide | TABLET | ORAL | 20200804 | N/A | NDA | NDA213674 | Astellas Pharma US, Inc. | ENZALUTAMIDE | 40 mg/1 | 1 BOTTLE in 1 CARTON (0469-0625-99) / 120 TABLET in 1 BOTTLE |
| 0469-0725-60 | 0469-0725 | HUMAN PRESCRIPTION DRUG | Xtandi | enzalutamide | TABLET | ORAL | 20200804 | N/A | NDA | NDA213674 | Astellas Pharma US, Inc. | ENZALUTAMIDE | 80 mg/1 | 1 BOTTLE in 1 CARTON (0469-0725-60) / 60 TABLET in 1 BOTTLE |
| 0469-1725-56 | 0469-1725 | HUMAN PRESCRIPTION DRUG | Xtandi | enzalutamide | TABLET | ORAL | 20200804 | N/A | NDA | NDA213674 | Astellas Pharma US, Inc. | ENZALUTAMIDE | 40 mg/1 | 1 BOTTLE in 1 CARTON (0469-1725-56) / 56 TABLET in 1 BOTTLE |